Showing results (121-130 of 134) with videos related to
Sort By:
Pageof 14
Science (New York, N.Y.)|June 29, 2002
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioningAlessandro Aiuti, Shimon Slavin, Memet Aker, et al.Journal of the Neurological Sciences|October 15, 2011
Preimplantation factor (PIF*) reverses neuroinflammation while promoting neural repair in EAE modelLola Weiss, Reuven Or, Richard C Jones, et al.The Journal of Clinical Investigation|August 3, 2007
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapyAlessandro Aiuti, Barbara Cassani, Grazia Andolfi, et al.Blood|October 24, 2002
Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000Reinhard A Seger, Tayfun Gungor, Bernd H Belohradsky, et al.Blood|November 18, 2006
A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host diseaseMargaret L Macmillan, Daniel Couriel, Daniel J Weisdorf, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 14, 2011
Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTRGregory A Hale, Smriti Shrestha, Jennifer Le-Rademacher, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 25, 2008
Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioningParameswaran Hari, Jeanette Carreras, Mei-Jie Zhang, et al.The New England Journal of Medicine|January 31, 2009
Gene therapy for immunodeficiency due to adenosine deaminase deficiencyAlessandro Aiuti, Federica Cattaneo, Stefania Galimberti, et al.Blood|September 26, 2012
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?Ulrike Bacher, Evgeny Klyuchnikov, Jennifer Le-Rademacher, et al.Blood|December 17, 2015
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donorsAbraham S Kanate, Alberto Mussetti, Mohamed A Kharfan-Dabaja, et al.Pageof 14